291 related articles for article (PubMed ID: 14662774)
1. Expression of NAG-1, a transforming growth factor-beta superfamily member, by troglitazone requires the early growth response gene EGR-1.
Baek SJ; Kim JS; Nixon JB; DiAugustine RP; Eling TE
J Biol Chem; 2004 Feb; 279(8):6883-92. PubMed ID: 14662774
[TBL] [Abstract][Full Text] [Related]
2. Troglitazone, a peroxisome proliferator-activated receptor gamma (PPAR gamma ) ligand, selectively induces the early growth response-1 gene independently of PPAR gamma. A novel mechanism for its anti-tumorigenic activity.
Baek SJ; Wilson LC; Hsi LC; Eling TE
J Biol Chem; 2003 Feb; 278(8):5845-53. PubMed ID: 12475986
[TBL] [Abstract][Full Text] [Related]
3. Activation of peroxisome proliferator-activated receptor gamma inhibits interleukin-1beta-induced membrane-associated prostaglandin E2 synthase-1 expression in human synovial fibroblasts by interfering with Egr-1.
Cheng S; Afif H; Martel-Pelletier J; Pelletier JP; Li X; Farrajota K; Lavigne M; Fahmi H
J Biol Chem; 2004 May; 279(21):22057-65. PubMed ID: 15023995
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of the peroxisome proliferator activated receptor gamma (PPARgamma) ligand induced apoptosis in colon cancer cells.
Shimada T; Kojima K; Yoshiura K; Hiraishi H; Terano A
Gut; 2002 May; 50(5):658-64. PubMed ID: 11950812
[TBL] [Abstract][Full Text] [Related]
5. 15-Deoxy-delta12,14-PGJ2, but not troglitazone, modulates IL-1beta effects in human chondrocytes by inhibiting NF-kappaB and AP-1 activation pathways.
Boyault S; Simonin MA; Bianchi A; Compe E; Liagre B; Mainard D; Bécuwe P; Dauça M; Netter P; Terlain B; Bordji K
FEBS Lett; 2001 Jul; 501(1):24-30. PubMed ID: 11457450
[TBL] [Abstract][Full Text] [Related]
6. Magnitude of peroxisome proliferator-activated receptor-gamma activation is associated with important and seemingly opposite biological responses in breast cancer cells.
Clay CE; Namen AM; Atsumi G; Trimboli AJ; Fonteh AN; High KP; Chilton FH
J Investig Med; 2001 Sep; 49(5):413-20. PubMed ID: 11523697
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptor gamma1 (PPARgamma1) expresses in rat mesangial cells and PPARgamma agonists modulate its differentiation.
Asano T; Wakisaka M; Yoshinari M; Iino K; Sonoki K; Iwase M; Fujishima M
Biochim Biophys Acta; 2000 Jun; 1497(1):148-54. PubMed ID: 10838168
[TBL] [Abstract][Full Text] [Related]
8. 15-Deoxy-delta(12,14) prostaglandin J2: a putative endogenous promoter of adipogenesis suppresses the ob gene.
Sinha D; Addya S; Murer E; Boden G
Metabolism; 1999 Jun; 48(6):786-91. PubMed ID: 10381155
[TBL] [Abstract][Full Text] [Related]
9. DR1-like element in human topoisomerase IIalpha gene involved in enhancement of etoposide-induced apoptosis by PPARgamma ligand.
Kanbe E; Abe A; Towatari M; Kawabe T; Saito H; Emi N
Exp Hematol; 2003 Apr; 31(4):300-8. PubMed ID: 12691917
[TBL] [Abstract][Full Text] [Related]
10. Early growth response factor-1 is a critical transcriptional mediator of peroxisome proliferator-activated receptor-gamma 1 gene expression in human aortic smooth muscle cells.
Fu M; Zhang J; Lin Y; Zhu X; Ehrengruber MU; Chen YE
J Biol Chem; 2002 Jul; 277(30):26808-14. PubMed ID: 12011097
[TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase inhibitors induce the expression of the tumor suppressor gene EGR-1, which results in the up-regulation of NAG-1, an antitumorigenic protein.
Baek SJ; Kim JS; Moore SM; Lee SH; Martinez J; Eling TE
Mol Pharmacol; 2005 Feb; 67(2):356-64. PubMed ID: 15509713
[TBL] [Abstract][Full Text] [Related]
12. Troglitazone antagonizes tumor necrosis factor-alpha-induced reprogramming of adipocyte gene expression by inhibiting the transcriptional regulatory functions of NF-kappaB.
Ruan H; Pownall HJ; Lodish HF
J Biol Chem; 2003 Jul; 278(30):28181-92. PubMed ID: 12732648
[TBL] [Abstract][Full Text] [Related]
13. Effect of PPARgamma ligands on the viability of gastric epithelial cells.
Kojima K; Shimada T; Mitobe Y; Yoshiura K; Hiraishi H; Terano A
Aliment Pharmacol Ther; 2002 Apr; 16 Suppl 2():67-73. PubMed ID: 11966526
[TBL] [Abstract][Full Text] [Related]
14. 15-Deoxy-delta 12,14-prostaglandin J2 and thiazolidinediones activate the MEK/ERK pathway through phosphatidylinositol 3-kinase in vascular smooth muscle cells.
Takeda K; Ichiki T; Tokunou T; Iino N; Takeshita A
J Biol Chem; 2001 Dec; 276(52):48950-5. PubMed ID: 11687581
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effects of PPARgamma agonists against oxidative insults in HT-22 cells.
Aoun P; Watson DG; Simpkins JW
Eur J Pharmacol; 2003 Jul; 472(1-2):65-71. PubMed ID: 12860474
[TBL] [Abstract][Full Text] [Related]
16. Induction of differentiation and peroxisome proliferator-activated receptor gamma expression in colon cancer cell lines by troglitazone.
Kato M; Kusumi T; Tsuchida S; Tanaka M; Sasaki M; Kudo H
J Cancer Res Clin Oncol; 2004 Feb; 130(2):73-9. PubMed ID: 14634802
[TBL] [Abstract][Full Text] [Related]
17. Vascular inflammation is negatively autoregulated by interaction between CCAAT/enhancer-binding protein-delta and peroxisome proliferator-activated receptor-gamma.
Takata Y; Kitami Y; Yang ZH; Nakamura M; Okura T; Hiwada K
Circ Res; 2002 Sep; 91(5):427-33. PubMed ID: 12215492
[TBL] [Abstract][Full Text] [Related]
18. Troglitazone inhibits cell growth and induces apoptosis of B-cell acute lymphoblastic leukemia cells with t(14;18).
Takenokuchi M; Saigo K; Nakamachi Y; Kawano S; Hashimoto M; Fujioka T; Koizumi T; Tatsumi E; Kumagai S
Acta Haematol; 2006; 116(1):30-40. PubMed ID: 16809887
[TBL] [Abstract][Full Text] [Related]
19. EGR1 expression: a calcium and ERK1/2 mediated PPARγ-independent event involved in the antiproliferative effect of 15-deoxy-Δ12,14-prostaglandin J2 and thiazolidinediones in breast cancer cells.
Chbicheb S; Yao X; Rodeau JL; Salamone S; Boisbrun M; Thiel G; Spohn D; Grillier-Vuissoz I; Chapleur Y; Flament S; Mazerbourg S
Biochem Pharmacol; 2011 May; 81(9):1087-97. PubMed ID: 21338579
[TBL] [Abstract][Full Text] [Related]
20. A new class of peroxisome proliferator-activated receptor gamma (PPARgamma) agonists that inhibit growth of breast cancer cells: 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes.
Qin C; Morrow D; Stewart J; Spencer K; Porter W; Smith R; Phillips T; Abdelrahim M; Samudio I; Safe S
Mol Cancer Ther; 2004 Mar; 3(3):247-60. PubMed ID: 15026545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
